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Summary.  We evaluated whether quantitative measurements of liver fibrosis with
recently developed diagnostics outperform histological staging in detecting natural
or interferon-induced changes. We compared Metavir staging, morphometry (area
and fractal dimension) and six blood tests in 157 patients with chronic hepatitis C
from two trials testing maintenance interferon for 96 weeks. Paired liver biopsies
and blood tests were available for 101 patients, and there was a significant
improvement in Metavir activity and a significant increase in blood tests reflecting
fibrosis quantity in patients treated with interferon when compared with controls –
all per cent changes in histological fibrosis measures were significantly increased in
F1 vs F2–4 stages only in the interferon group. For the whole population studied
between weeks 0 and 96, there was significant progression only in the area of
fibrosis (AOF) (P = 0.026), FibroMeter (P = 0.020) and CirrhoMeter (P = 0.003).
With regards to dynamic reproducibility, agreement was good (ric ≥ 0.72) only for
Metavir fibrosis score, FibroMeter and CirrhoMeter. The per cent change in AOF
was significantly higher than that of fractal dimension (P = 0.003) or Metavir fibrosis
score (P = 0.015). CirrhoMeter was the only blood test with a change significantly
higher than that of AOF (P = 0.039). AOF and two blood tests, reflecting fibrosis
quantity, have high sensitivity and/or reproducibility permitting the detection of a
small progression in liver fibrosis over two years. A blood test reflecting fibrosis
quantity is more sensitive and reproducible than morphometry. The study also shows
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